These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18706823)

  • 1. Synthesis and biodistribution of 34mCl-labeled 2-chloro-2-deoxy-d-glucose: a major impurity in [18F]FDG injection.
    Fukumura T; Takei M; Suzuki K
    Appl Radiat Isot; 2008 Dec; 66(12):1905-9. PubMed ID: 18706823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of 2-deoxy-2-chloro-d-glucose impurity analysis in [(18)F]FDG by three potential-time waveforms of high-performance liquid chromatography/pulsed amperometric detection.
    Farn SS; Yeh YH; Lin WJ; Shen LH
    Nucl Med Biol; 2009 Feb; 36(2):225-31. PubMed ID: 19217535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins.
    Wuest F; Berndt M; Bergmann R; van den Hoff J; Pietzsch J
    Bioconjug Chem; 2008 Jun; 19(6):1202-10. PubMed ID: 18481886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved quality control of [18F]FDG by HPLC with UV detection.
    Nakao R; Ito T; Yamaguchi M; Suzuki K
    Nucl Med Biol; 2005 Nov; 32(8):907-12. PubMed ID: 16253817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote control production of an aqueous solution of no-carrier-added 34mCl- via the 32S(alpha,pn) nuclear reaction.
    Takei M; Nagatsu K; Fukumura T; Suzuki K
    Appl Radiat Isot; 2007 Sep; 65(9):981-6. PubMed ID: 17574427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and the role of ethanol and radioactive concentration.
    Jacobson MS; Dankwart HR; Mahoney DW
    Appl Radiat Isot; 2009 Jun; 67(6):990-5. PubMed ID: 19231219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine.
    Niederkohr RD; Quon A
    Clin Nucl Med; 2007 Apr; 32(4):302-3. PubMed ID: 17413580
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.
    Hamacher K; Coenen HH; Stöcklin G
    J Nucl Med; 1986 Feb; 27(2):235-8. PubMed ID: 3712040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of 34m Cl and 38 Cl via the (d,α) reaction on 36 Ar and nat Ar gas at 8.4 MeV.
    Engle JW; Barnhart TE; DeJesus OT; Nickles RJ
    Appl Radiat Isot; 2011 Jan; 69(1):75-9. PubMed ID: 20884215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No carrier added synthesis of O-(2'-[18F]fluoroethyl)-L-tyrosine via a novel type of chiral enantiomerically pure precursor, NiII complex of a (S)-tyrosine Schiff base.
    Krasikova RN; Kuznetsova OF; Fedorova OS; Maleev VI; Saveleva TF; Belokon YN
    Bioorg Med Chem; 2008 May; 16(9):4994-5003. PubMed ID: 18378460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid synthesis of [18F]FDG without an evaporation step using an ionic liquid.
    Kim HW; Jeong JM; Lee YS; Chi DY; Chung KH; Lee DS; Chung JK; Lee MC
    Appl Radiat Isot; 2004 Dec; 61(6):1241-6. PubMed ID: 15388116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous analysis of FDG, ClDG and Kryptofix 2.2.2 in [18F]FDG preparation by high-performance liquid chromatography with UV detection.
    Nakao R; Ito T; Yamaguchi M; Suzuki K
    Nucl Med Biol; 2008 Feb; 35(2):239-44. PubMed ID: 18312835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and catabolism of 18F-labeled N-epsilon-fructoselysine as a model of Amadori products.
    Hultsch C; Hellwig M; Pawelke B; Bergmann R; Rode K; Pietzsch J; Krause R; Henle T
    Nucl Med Biol; 2006 Oct; 33(7):865-73. PubMed ID: 17045166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy.
    Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):16-23. PubMed ID: 17372569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints.
    Chakraborty S; Das T; Banerjee S; Subramanian S; Sarma HD; Venkatesh M
    Nucl Med Biol; 2006 May; 33(4):585-91. PubMed ID: 16720253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4,6-Tri-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranosyl phenylthiosulfonate: a thiol-reactive agent for the chemoselective 18F-glycosylation of peptides.
    Prante O; Einsiedel J; Haubner R; Gmeiner P; Wester HJ; Kuwert T; Maschauer S
    Bioconjug Chem; 2007; 18(1):254-62. PubMed ID: 17226980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to quantify at late imaging a release rate of 18F-FDG in tissues.
    Laffon E; Allard M; Marthan R; Ducassou D
    C R Biol; 2005 Aug; 328(8):767-72. PubMed ID: 16125654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG.
    Hays MT; Watson EE; Thomas SR; Stabin M
    J Nucl Med; 2002 Feb; 43(2):210-4. PubMed ID: 11850487
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) and the role of reductant stabilisers.
    Fawdry RM
    Appl Radiat Isot; 2007 Nov; 65(11):1193-201. PubMed ID: 17669662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
    Dunn JT; Anthony K; Amiel SA; Marsden PK
    J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.